KRYS

Krystal Biotech Stock Analysis

AI Rating

Neutral
  • Quality8/10
  • Growth↑ 9/10
  • Value↓ 1/10
Krystal Biotech sales and earnings growth
KRYS Growth
Great
  • Revenue Y/Y↑ 33.94%
  • EPS Y/Y↑ 126.92%
  • FCF Y/Y↑ 58.87%
Krystal Biotech gross and profit margin trends
KRYS Profitability
Great
  • Gross margin ↑ 94.10%
  • EPS margin↑ 52.60%
  • ROIC 5Y↑ 7.69%
Krystal Biotech net debt vs free cash flow
KRYS Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Krystal Biotech stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗